Literature DB >> 2495793

Phosphorylation of two cytosolic proteins. An early event of T-cell activation.

J F Peyron1, C Aussel, B Ferrua, H Häring, M Fehlmann.   

Abstract

T lymphocytes can be activated to proliferate by triggering the T-cell antigen-receptor complex (CD3-Ti) with anti-CD3 (Cluster of Differentiation 3) monoclonal antibody (mAb) or with the mitogenic lectin phytohaemagglutinin A (PHA). We have investigated the relationship between lymphocyte activation and protein phosphorylation in the human leukaemic T-cell line Jurkat. Incubation of 32P-labelled Jurkat cells with anti-CD3 mAb or PHA induced the phosphorylation of two cytosolic proteins that migrate with apparent Mr values of 21,000 (pp21) and 23,000 (pp23) and pI values of 5.1 and 5.0 respectively. Peptide mapping of the two proteins produced the same phosphopeptides pattern, suggesting that pp21 and pp23 are closely related. The phosphorylation of pp21 and pp23 induced by anti-CD3 mAb appeared to be transient, since it was already detected 2 min after the addition of the mAb, reached a maximum at 10 min and recovered its basal level after 1 h. Phosphorylation of pp21 and pp23 could also be elicited by the Ca2+ ionophore A23187 and sodium orthovanadate (Na3VO4), two agents that bypass the T-cell-receptor complex and produced an increase in cytosolic Ca2+ concentration. In addition, we found that vanadate, like the Ca2+ ionophore, induced the secretion of interleukin-2 (IL-2) when used in combination with a submitogenic concentration of the phorbol ester 12-O-tetradecanoylphorbol 13-acetate. These results show that the Ca2+-dependent phosphorylation of pp21 and pp23 represents an early event in the process of signal transduction through the CD3-Ti receptor complex.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495793      PMCID: PMC1138390          DOI: 10.1042/bj2580505

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

2.  Human interleukin 2. Detection at the picomolar level by sandwich enzyme immunoassay.

Authors:  B Ferrua; C Aussel; M Fehlmann
Journal:  J Immunol Methods       Date:  1987-03-12       Impact factor: 2.303

3.  Changes in protein phosphorylation in Rous sarcoma virus-transformed chicken embryo cells.

Authors:  J A Cooper; T Hunter
Journal:  Mol Cell Biol       Date:  1981-02       Impact factor: 4.272

4.  Rapid decrease of phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets.

Authors:  M M Billah; E G Lapetina
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

5.  Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate.

Authors:  G Swarup; S Cohen; D L Garbers
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

6.  OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

Authors:  J P Van Wauwe; J R De Mey; J G Goossens
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

7.  T-cell mitogens cause early changes in cytoplasmic free Ca2+ and membrane potential in lymphocytes.

Authors:  R Y Tsien; T Pozzan; T J Rink
Journal:  Nature       Date:  1982-01-07       Impact factor: 49.962

8.  Thrombin-induced phosphodiesteratic cleavage of phosphatidylinositol bisphosphate in human platelets.

Authors:  B W Agranoff; P Murthy; E B Seguin
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

9.  Human interleukin 1: purification and properties.

Authors:  L B Lachman
Journal:  Fed Proc       Date:  1983-06

10.  A phorbol ester (TPA) can replace macrophages in human lymphocyte cultures stimulated with a mitogen but not with an antigen.

Authors:  G A Koretzky; R P Daniele; P C Nowell
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

View more
  8 in total

1.  Phosphorylation of stathmin modulates its function as a microtubule depolymerizing factor.

Authors:  F J Moreno; J Avila
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

2.  Stathmin interaction with a putative kinase and coiled-coil-forming protein domains.

Authors:  A Maucuer; J H Camonis; A Sobel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

3.  Stathmin is expressed by the proliferating hepatocytes during liver regeneration.

Authors:  D C Rowlands; R F Harrison; N A Jones; A Williams; S G Hubscher; G Brown
Journal:  Clin Mol Pathol       Date:  1995-04

4.  The phosphorylation of stathmin by MAP kinase.

Authors:  I A Leighton; P Curmi; D G Campbell; P Cohen; A Sobel
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

5.  Expression of transfected stathmin cDNA reveals novel phosphorylated forms associated with developmental and functional cell regulation.

Authors:  V Doye; S Le Gouvello; T Dobransky; H Chneiweiss; L Beretta; A Sobel
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

6.  Molecular characterization of human stathmin expressed in Escherichia coli: site-directed mutagenesis of two phosphorylatable serines (Ser-25 and Ser-63).

Authors:  P A Curmi; A Maucuer; S Asselin; M Lecourtois; A Chaffotte; J M Schmitter; A Sobel
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

7.  Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours.

Authors:  P A Curmi; C Noguès; S Lachkar; N Carelle; M P Gonthier; A Sobel; R Lidereau; I Bièche
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

8.  Overexpression of the stathmin gene in a subset of human breast cancer.

Authors:  I Bièche; S Lachkar; V Becette; C Cifuentes-Diaz; A Sobel; R Lidereau; P A Curmi
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.